Insider Transactions in Q2 2025 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,965
-1.87%
|
$8,895
$3.63 P/Share
|
|
Jun 02
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,658
-0.59%
|
$25,974
$3.63 P/Share
|
|
Jun 02
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,712
-1.0%
|
$8,136
$3.63 P/Share
|
|
Jun 02
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,747
-1.23%
|
$14,241
$3.63 P/Share
|
|
Jun 02
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,802
-1.85%
|
$11,406
$3.63 P/Share
|
|
Jun 02
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,255
-2.03%
|
$9,765
$3.63 P/Share
|
|
Jun 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
4,080
+5.03%
|
-
|
|
Jun 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
3,766
+4.78%
|
-
|
|
May 05
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-2.47%
|
$20,836
$4.1 P/Share
|
|
Apr 03
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-2.41%
|
$20,836
$4.15 P/Share
|